MITH Brussel Overview

Headquarters: K, Be
Website: mima.research.vub.be
Industry: Research Services
Employees: 1
Founded: 2005
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

Theranostics Radiopharmacy Nanobodies Radiochemistry Radiopharmaceuticals Preclinical Nuclear Imaging Image guided surgery PET/CT SPECT/CT Intravital microscopy Targeted radionuclide therapy

About MITH Brussel

The Molecular Imaging and Therapy (MITH) research group is a component of the cutting-edge core facility, ICMI (VUB, Brussel). We are specialized in protein-based radiotheranostics, we excel in every stage — from Nanobody generation, through the design and preclinical validation of fluorescently and/or radiolabeled tracers, to the ultimate milestone of clinical validation. Key Focus Areas: Nanobody generation and selection. Protein-based radiochemistry for imaging and therapy. Image-Guided Surgery: Revolutionizing precision in medical procedures. Preclinical: State-of-the-art facilities for rigorous testing and optimization. Bridging translational research and clinical trials. 🚀 Join us in shaping the future of medicine! 🌐 #Innovation #Radiopharmaceuticals #Theranostics #MedicalResearch #PrecisionMedicine #Nanobodies